Research Institute of Life and Health Sciences, Faculty of Medicine, Kokshetau University named after Sh. Ualikhanov, Kokshetau, Kazakhstan.
Central Asian Institute for Medical Research, Astana, Kazakhstan.
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3361-3371. doi: 10.31557/APJCP.2023.24.10.3361.
According to the International Agency for Research on Cancer, ongoing demographic changes will lead to an increase in the number of deaths from breast cancer (BC) per year in the vast majority of regions. In 2040 it is expected that 1.04 million people worldwide will die from this malignancy, including 2,380 women in Kazakhstan.
The retrospective study (2009-2018) was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the generally accepted methodology used in sanitary statistics. The data were used to calculate the average percentage change (APС) using the Joinpoint regression analysis to determine the trend over the study period.
During 10 years 12,958 women died from BC. An average age of the death was 61.6 years (95%CI=60.6-62.6) and tended to increase (APC=+0.6%, R2=0.6117). Age-specific rates had a bimodal increase with peak rates at 70-74 years - 76.7±5.5 (APC=+3.4%, R2=0.2656) and 80-84 years - 78.0±9.1 (APC=+3.7%, R2=0.0875). The age-standardized rate was 13.9 per 100,000 of female population, and the trend has decreased. When compiling thematic maps, mortality rates were determined on the basis of standardized indicators: low - up to 12.5, average - from 12.5 to 15.2, high - above 15.2 per 100,000. The results of the spatial analysis showed the regions with a higher levels of BC mortality rate per 100,000: Pavlodar (16.9), Almaty (19.2) and Astana cities (19.3).
Age-standardized mortality rates had a strong downward trend (APC=-4.0%, R2=0.9218). The decrease mostly is due to a large coverage of the population by mammography screening and to an improvement in the effectiveness of breast cancer treatment.
根据国际癌症研究机构的数据,人口结构的持续变化将导致绝大多数地区乳腺癌(BC)死亡人数逐年增加。到 2040 年,预计全球将有 104 万人死于这种恶性肿瘤,其中哈萨克斯坦有 2380 名女性。
本回顾性研究(2009-2018 年)采用描述性和分析性肿瘤流行病学方法进行。根据卫生统计学中普遍采用的方法,确定广泛的、粗略的和年龄特异性发病率。使用这些数据,通过 Joinpoint 回归分析计算平均百分比变化(APC),以确定研究期间的趋势。
10 年内,有 12958 名女性死于 BC。平均死亡年龄为 61.6 岁(95%CI=60.6-62.6),且呈上升趋势(APC=+0.6%,R2=0.6117)。年龄特异性发病率呈双峰式增长,峰值分别出现在 70-74 岁(76.7±5.5,APC=+3.4%,R2=0.2656)和 80-84 岁(78.0±9.1,APC=+3.7%,R2=0.0875)。标准化发病率为每 10 万名女性 13.9 例,呈下降趋势。在编制专题地图时,死亡率是根据标准化指标确定的:低-低于 12.5,中-12.5-15.2,高-高于 15.2/10 万。空间分析结果显示,BC 死亡率较高的地区有:巴甫洛达尔(16.9)、阿拉木图(19.2)和阿斯塔纳(19.3)。
标准化死亡率呈明显下降趋势(APC=-4.0%,R2=0.9218)。这种下降主要归因于对乳腺癌筛查的广泛覆盖,以及乳腺癌治疗效果的提高。